Northeast India’s Only English and Hindi Satellite News Channel

Covaxin can work against mutated coronavirus: Bharat Biotech

First Published: 29th December, 2020 20:36 IST

Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker Krishna Ella said

Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker Krishna Ella said on Tuesday.

He also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology and now undergoing phase 3 trials.

“It (coronavirus) is expected to have a lot of mutation and you can be rest assured this vaccine will also protect against that (mutated) virus because of two hypotheses… “So you have these two components in the inactivated vaccine. It will also take care of those mutations,” Ella said during a virtual programme organised by CSIR-Indian Institute of Chemical Technology.

He was replying to a query on the new strain of coronavirus that was detected in the United Kingdom recently.

Ella said mutation was not unexpected and the virus mutates on its own to reach more number of people as it is a non-living organism.

The executive said Covaxin, now undergoing Phase 3 trials involving about 20,000 volunteers, balances both safety and efficacy.

Six people who returned to India from the UK have tested positive for the new mutated strain of coronavirus, the Union Health Ministry said on Tuesday.

The presence of the new UK variant of the coronavirus has already been reported by Denmark, the Netherlands, Australia, Italy, Sweden, France, Spain, Switzerland, Germany, Canada, Japan, Lebanon and Singapore so far. PTI

COMMENTS

Leave a Reply

Your email address will not be published. Required fields are marked *

WE RECOMMEND

Banner
Epigamia Co-Founder Rohan Mirchandani Passes Away at 41 Due to Heart Attack

The company’s leadership decided to continue to manage the business.

23rd December 2024
Banner
7 Indian nationals injured in Magdeburg Christmas market attack

Of these,three have been discharged from the hospital, while the Indian Mission is closely monitoring the condition of the remaining victims.

22nd December 2024
Banner
Nagaland MP Accuses Rahul Gandhi of Standing Too Close to Her, Making Her Feel Uncomfortable

MP Phangnon Konyak has filed a complaint with Rajya Sabha Chairman against Congress leader Rahul Gandhi

19th December 2024
Banner
GRAP Stage IV reintroduced in NCR as AQI breaches 400 mark

This comes after the Air Quality Index in Delhi breached the 400 mark. AQI was recorded as 399 at 9 pm and 401 at 10 pm.

17th December 2024
Banner
India, Bangladesh to commemorate 1971 war ‘Vijay Diwas’ with annual exchange of veterans today

The event also gave an opportunity to the tribal community to showcase their talent.

16th December 2024